Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study

被引:76
|
作者
Pulignano, Giovanni [1 ]
Del Sindaco, Donatella [2 ]
Di Lenarda, Andrea [3 ]
Tarantini, Luigi [4 ]
Cioffi, Giovanni [5 ]
Gregori, Dario [6 ]
Tinti, Maria Denitza [1 ]
Monzo, Luca [1 ]
Minardi, Giovanni [1 ]
机构
[1] San Camillo Hosp, Heart Failure Clin, Div Cardiol, Coronary Care Unit, Trieste, Italy
[2] Inst Care & Res Elderly INRCA, Heart Failure Unit, Div Cardiol, Trieste, Italy
[3] Cardiovasc Ctr & Univ, Trieste, Italy
[4] San Martino Hosp, Heart Failure Clin, Div Cardiol, Belluno, Italy
[5] Villa Bianca Hosp, Heart Failure Clin, Div Cardiol, Trento, Italy
[6] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy
关键词
cost-effectiveness; elderly; frailty; heart failure; management programs; ELDERLY-PATIENTS; FUNCTIONAL DECLINE; CARE; MULTIDISCIPLINARY; PREVENT; INTERVENTION; CARDIOLOGY; MORTALITY; ADMISSION; OUTCOMES;
D O I
10.2459/JCM.0b013e328339d981
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Disease management programs (DMP) improve outcomes in patients with heart failure. Because older heart failure patients represent a heterogeneous population, the aim of this study was to determine which patients benefit mostly from a DMP, by means of their frailty profile. Setting Heart failure outpatient clinic. Methods Consecutive (n = 173) patients aged more than 70 years were randomized to a multidisciplinary DMP (n = 86) or usual care (n = 87). A modified frailty score (range 1-6) was used as an index of global functional impairment. Results Mild to moderate frailty (frailty score = 2-3) was associated with significant improvements in outcomes (death and/or heart failure admission, heart failure admissions and all-cause admissions) in DMP patients vs. usual care. Even in more frail patients (frailty score = 4-6) a significant reduction in heart failure admissions was observed. By contrast, nonfrail patients (frailty score = 1) did not derive significant benefit. In the cost-effectiveness analysis, the mean savings per patient, stratified according to their frailty score, were (sic) -1003.31 for frailty score 1 (95% confidence interval -3717.00-1709.00), (sic) 1104.72 for frailty score 2 (-280.6-2491.00), (sic) 2635.42 for frailty score 3 (352.60-4917.00, P = 0.025) and (sic) 419.53 for frailty score 4-6 (-1909.00-2749.00). Intervention was therefore significantly cost saving in moderately frail, but not in nonfrail or severely frail patients. Thus, DMP was dominant (i.e. both less costly and more effective than usual care) in moderately frail patients. At sensitivity analysis, DMP remained dominant even to changes in cost of intervention and hospitalizations. Conclusion This suggests that an intensive, hospital-based DMP appears to be more effective in older patients with mild-to-moderate levels of frailty. Thus, a multidimensional assessment of frailty seems to be a useful tool for appropriate selection of model of care. J Cardiovasc Med 11: 739-747 (C) 2010 Italian Federation of Cardiology.
引用
收藏
页码:739 / 747
页数:9
相关论文
共 50 条
  • [1] Cost-Effectiveness of study nurses in the management of patients with heart failure. A systematic review
    Biermann, J.
    Mostardt, S.
    Neumann, T.
    Erbel, R.
    Wasem, J.
    Neumann, A.
    HERZ, 2010, 35 (04) : 273 - 283
  • [2] Long-Term Cost-Effectiveness of Disease Management in Systolic Heart Failure
    Miller, George
    Randolph, Stephen
    Forkner, Emma
    Smith, Brad
    Galbreath, Autumn Dawn
    MEDICAL DECISION MAKING, 2009, 29 (03) : 325 - 333
  • [3] Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study
    Neumann, Anja
    Mostardt, Sarah
    Biermann, Janine
    Gelbrich, Goetz
    Goehler, Alexander
    Geisler, Benjamin P.
    Siebert, Uwe
    Stoerk, Stefan
    Ertl, Georg
    Angerrmann, Christiane E.
    Wasem, Juergen
    CLINICAL RESEARCH IN CARDIOLOGY, 2015, 104 (04) : 304 - 309
  • [4] Cost-Effectiveness of Cardiac Rehabilitation in Older Adults With Coronary Heart Disease
    Shepard, Donald S.
    Zakir, Shehreen
    Gaalema, Diann E.
    Ades, Philip A.
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2024, 44 (02) : 107 - 114
  • [5] Cost-effectiveness of ace inhibitors versus ARBs in heart failure management
    Elendu, Chukwuka
    Amaechi, Dependable C.
    Elendu, Tochi C.
    Amaechi, Emmanuel C.
    Elendu, Ijeoma D.
    Jingwa, Klein A.
    Chiegboka, Sobechukwu F.
    Bhadana, Umesh
    Abdelatti, Abdelrahman M. S.
    Ikeji, Ifeanyi V.
    Atmadibrata, Jadzia C.
    Mohamed, Ahmed S. F.
    Sharmila, Umar Janibabu
    Soltan, Fathy E. A. E.
    Abbas, Nada K.
    Eldorghamy, Mariam M. F.
    Gurbanova, Tuvakbibi
    Okeme, Arome K. B.
    Okeke, Arinze A.
    Esangbedo, Ikpembhosa J.
    MEDICINE, 2024, 103 (36) : e39496
  • [6] Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure
    Reed, Shelby D.
    Neilson, Matthew P.
    Gardner, Matthew
    Li, Yanhong
    Briggs, Andrew H.
    Polsky, Daniel E.
    Graham, Felicia L.
    Bowers, Margaret T.
    Paul, Sara C.
    Granger, Bradi B.
    Schulman, Kevin A.
    Whellan, David J.
    Riegel, Barbara
    Levy, Wayne C.
    AMERICAN HEART JOURNAL, 2015, 170 (05) : 951 - 960
  • [7] Cost-effectiveness of a follow-up program for older patients with heart failure: a randomized controlled trial
    Gonzalez-Guerrero, Jose L.
    Hernandez-Mocholi, Miguel A.
    Ribera-Casado, Jose M.
    Garcia-Mayolin, Nieves
    Alonso-Fernandez, Teresa
    Gusi, Narcis
    EUROPEAN GERIATRIC MEDICINE, 2018, 9 (04) : 523 - 532
  • [8] Cost-effectiveness of a follow-up program for older patients with heart failure: a randomized controlled trial
    José L. González-Guerrero
    Miguel A. Hernández-Mocholi
    José M. Ribera-Casado
    Nieves García-Mayolín
    Teresa Alonso-Fernández
    Narcís Gusi
    European Geriatric Medicine, 2018, 9 : 523 - 532
  • [9] Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain
    Alcazar-Arroyo, Roberto
    Crespo-Leiro, Maria G.
    Bover, Jordi
    Oliva, Juan
    Sequera-Mutiozabal, Miren
    Gradari, Simona
    Marinez-Lopez, Anisia
    Lopez-Chicheri, Blanca
    Vidal-Vilar, Neus
    Aceituno, Susana
    Cobo, Marta
    NEFROLOGIA, 2024, 44 (05): : 709 - 720
  • [10] Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand
    Permsuwan, Unchalee
    Phrommintikul, Arintaya
    Silavanich, Voratima
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 579 - 588